Development of stapled oxyntomodulin-FC fusion proteins for the treatment of diabetes and obesity
Ended Project Grant Awarded Last action
- Award ID
- R43DK117740
- Recipient
-
Transira Therapeutics LLC UEI M2NZMMLMNGK9
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,000
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Amherst, NY 14228, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,000 |
Quick answers
Who received award R43DK117740?
R43DK117740 was awarded to Transira Therapeutics LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 18, 2018.
How much is award R43DK117740 worth?
$224,000 has been obligated on R43DK117740.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award